CALIPER Program, Department of Pediatric Laboratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Clin Chem. 2013 Sep;59(9):1393-405. doi: 10.1373/clinchem.2013.204222. Epub 2013 May 1.
Reference intervals are indispensable in evaluating laboratory test results; however, appropriately partitioned pediatric reference values are not readily available. The Canadian Laboratory Initiative for Pediatric Reference Intervals (CALIPER) program is aimed at establishing the influence of age, sex, ethnicity, and body mass index on biochemical markers and developing a comprehensive database of pediatric reference intervals using an a posteriori approach.
A total of 1482 samples were collected from ethnically diverse healthy children ages 2 days to 18 years and analyzed on the Abbott ARCHITECT i2000. Following the CLSI C28-A3 guidelines, age- and sex-specific partitioning was determined for each analyte. Nonparametric and robust methods were used to establish the 2.5th and 97.5th percentiles for the reference intervals as well as the 90% CIs.
New pediatric reference intervals were generated for 14 biomarkers, including α-fetoprotein, cobalamin (vitamin B12), folate, homocysteine, ferritin, cortisol, troponin I, 25(OH)-vitamin D [25(OH)D], intact parathyroid hormone (iPTH), thyroid-stimulating hormone, total thyroxine (TT4), total triiodothyronine (TT3), free thyroxine (FT4), and free triiodothyronine. The influence of ethnicity on reference values was also examined, and statistically significant differences were found between ethnic groups for FT4, TT3, TT4, cobalamin, ferritin, iPTH, and 25(OH)D.
This study establishes comprehensive pediatric reference intervals for several common endocrine and immunochemical biomarkers obtained in a large cohort of healthy children. The new database will be of global benefit, ensuring appropriate interpretation of pediatric disease biomarkers, but will need further validation for specific immunoassay platforms and in local populations as recommended by the CLSI.
参考区间在评估实验室检测结果中不可或缺;然而,适用于儿科的参考值尚未明确。加拿大儿科参考区间倡议(CALIPER)计划旨在确定年龄、性别、种族和体重指数对生化标志物的影响,并采用回溯法建立一个综合的儿科参考区间数据库。
共采集了 1482 份来自不同种族的健康儿童(2 天至 18 岁)的样本,在 Abbott ARCHITECT i2000 上进行分析。根据 CLSI C28-A3 指南,对每个分析物进行了年龄和性别特异性划分。采用非参数和稳健方法确定参考区间的 2.5%和 97.5%分位数以及 90%置信区间。
生成了 14 种生物标志物的新儿科参考区间,包括甲胎蛋白、钴胺素(维生素 B12)、叶酸、同型半胱氨酸、铁蛋白、皮质醇、肌钙蛋白 I、25-羟维生素 D [25(OH)D]、完整甲状旁腺激素(iPTH)、促甲状腺激素、总甲状腺素(TT4)、总三碘甲状腺原氨酸(TT3)、游离甲状腺素(FT4)和游离三碘甲状腺原氨酸。还研究了种族对参考值的影响,发现不同种族之间 FT4、TT3、TT4、钴胺素、铁蛋白、iPTH 和 25(OH)D 的参考值存在统计学差异。
本研究为大量健康儿童的常见内分泌和免疫化学标志物建立了全面的儿科参考区间。新数据库将具有全球效益,确保对儿科疾病生物标志物的正确解读,但需要根据 CLSI 的建议,在特定免疫分析平台和当地人群中进一步验证。